Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,801 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details
Completed

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT01471782

Conditions
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Children's Hospital Denver Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering New York, United States
View all 30 locations
View Trial Details
Completed

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

NCT00726934

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +25 more
Locations
  • Rady Children's Hospital San Diego San Diego, California, United States
  • Riley Hospital for Children at IU Health Indianapolis, Indiana, United States
  • Maimonides Medical Center Brooklyn, New York, United States
  • NYU Langone Medical Center New York, United States
View Trial Details
Completed

Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT00873093

Conditions
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, +16 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 171 locations
View Trial Details
Completed

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

NCT01520922

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations
  • Novartis Investigative Site Tuscon, Arizona, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Fort Myers, Florida, United States
  • Novartis Investigative Site St. Petersburg, Florida, United States
View all 33 locations
View Trial Details
Completed

Treatment of Adult Ph+ LAL With BMS-354825

NCT00391989

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Ospedale San Donato USL 8 Arezzo, Italy
  • Università degli Studi di Bari Bari, Italy
  • Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy
  • Azienda Spedali Civili Brescia, Italy
View all 36 locations
View Trial Details

Related conditions